25Indexed trials
mesh condition
Neuralgia
Intelligence
Neuralgia intelligence: 25 indexed trials, 4 recruiting studies, 24 sponsors across 25 countries.
4Recruiting
24Sponsors
25Countries
Leading sponsors
GlaxoSmithKline20 recruiting
Assistance Publique Hopitaux De Marseille11 recruiting
Biohaven Therapeutics Ltd.10 recruiting
Bioness Inc10 recruiting
Bristol-Myers Squibb10 recruiting
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)10 recruiting
Daiichi Sankyo10 recruiting
Eli Lilly and Company10 recruiting
Fondation Hôpital Saint-Joseph11 recruiting
InSightec11 recruiting
Indiana University10 recruiting
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's10 recruiting
Geographic activity
United States10trials
Canada3trials
Turkey (Türkiye)2trials
Taiwan2trials
Poland2trials
France2trials
China2trials
India2trials
Japan1trials
Denmark1trials
Italy1trials
Israel1trials
Leading interventions
pregabalin2trials
Gabapentin prescriptions2trials
BHV-70001trials
Conventional Physical therapy1trials
Conventional physical therapy program1trials
DS-1971a1trials
Duloxetine1trials
Diphenhydramine1trials
Far-Infrared Radiation (FIR) Socks1trials
Gabapentin1trials
BMS-7416721trials
Axon Therapy and CMM1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.